Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_assertion type Assertion NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_head.
- NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_assertion description "[However, the unfavorable genotype ERCC2 2251A>C (P = 0.006), tumor invasion depth (P = 0.025), lymph node metastasis (P = 0.011) and cancer stage (P = 0.008) were significantly correlated with early relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_provenance.
- NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_assertion evidence source_evidence_literature NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_provenance.
- NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_assertion SIO_000772 18267032 NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_provenance.
- NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_assertion wasDerivedFrom befree-20140225 NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_provenance.
- NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_assertion wasGeneratedBy ECO_0000203 NP637978.RAPmfLwS2ir6QWe1t4gy__IXzScQRmhB-6_9zfY_uvGYQ130_provenance.